GB754885A - Recovery of heparin - Google Patents
Recovery of heparinInfo
- Publication number
- GB754885A GB754885A GB18577/54A GB1857754A GB754885A GB 754885 A GB754885 A GB 754885A GB 18577/54 A GB18577/54 A GB 18577/54A GB 1857754 A GB1857754 A GB 1857754A GB 754885 A GB754885 A GB 754885A
- Authority
- GB
- United Kingdom
- Prior art keywords
- heparin
- protein
- solution
- salt
- precipitated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Peptides Or Proteins (AREA)
Abstract
Heparin is recovered from an alkaline or substantially neutral aqueous solution containing also a protein by adding a soluble salt of an alkali metal, or of ammonium, or of an alkaline earth metal to said solution, acidifying the solution to precipitate the protein, removing the protein and recovering the heparin from the remaining solution. The solution of the proteinheparin mixture may have a pH between 7 and 10. Sufficient soluble salt may be added to produce an anion concentration of at least about one mol. per litre. Suitable salts which may be used are alkali metal and ammonium citrates, halides, acetates, sulphates and thiocyanates, and alkaline earth metal halides, acetates and citrates, e.g. sodium chloride, sodium thiocyante, calcium chloride and acetate, and ammonium sulphate and citrate may be used. When sodium chloride is used, the solution may be acidified to a pH of less than 4, e.g. when between about 100 grams and about 150 grams of sodium chloride is used, the solution may be acidified to a pH of about 2.5 to precipitate the protein. The heparin solution containing protein may be obtained by autolyzing heparinbearing animal tissue, extracting the autolyzed tissue with an aqueous solution of alkali, e.g. ammonium sulphate and sodium hydroxide, heating the mixture, filtering to remove the coagulated substance, acidifying to precipitate a protein-heparin complex which is dissolved in water at a pH of at least 7 to form the solution for the above process. The process is applicable to heparin mixtures containing denatured or native proteins. The temperature at which protein coagulation is effected may vary from about 0 DEG C. to about 100 DEG C.-heating during or after the acidification being particularly useful. Suitable acids which may be used for the acidification are strong inorganic and strong organic acids such as sulphuric, hydrochloric and trichloroacetic acids. The heparin is preferably precipitated from the protein-free solution by adding a water-miscible organic solvent such as methyl or ethyl alcohol or acetone. When the soluble salt used in the above process is not very soluble in ethyl alcohol or acetone, it is desirable to subject the filtrate to dialysis to remove the salt before the heparin is precipitated. Alternatively, the precipitated heparin containing the salt may be dissolved in water, the solution subjected to dialysis to remove the salt, and reprecipitating the heparin with alcohol or acetone. The process is suitable for the purification of heparin, e.g. impure heparin can be mixed with an acid precipitable protein such as casein, the mixture is acidified and the resulting precipitated heparin-protein complex can then be treated by the above process. A number of detailed examples are given. U.S.A. Specification 2,623,001 is referred to.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US754885XA | 1953-07-01 | 1953-07-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB754885A true GB754885A (en) | 1956-08-15 |
Family
ID=22126091
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB18577/54A Expired GB754885A (en) | 1953-07-01 | 1954-06-24 | Recovery of heparin |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB754885A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105399865A (en) * | 2014-09-16 | 2016-03-16 | 东营天东制药有限公司 | Efficient heparin sodium bulk drug refining process |
CN115286725A (en) * | 2022-08-31 | 2022-11-04 | 山东万邦赛诺康生化制药股份有限公司 | Preparation method of high-purity low-molecular-weight heparin |
-
1954
- 1954-06-24 GB GB18577/54A patent/GB754885A/en not_active Expired
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105399865A (en) * | 2014-09-16 | 2016-03-16 | 东营天东制药有限公司 | Efficient heparin sodium bulk drug refining process |
CN115286725A (en) * | 2022-08-31 | 2022-11-04 | 山东万邦赛诺康生化制药股份有限公司 | Preparation method of high-purity low-molecular-weight heparin |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109096161B (en) | Preparation method of N-acetylcysteine | |
US3936375A (en) | Process for dewatering a proteinaceous, aqueous sludge and for removing and recovering precipitating agents from a precipitate containing proteinaceous substances | |
GB754885A (en) | Recovery of heparin | |
US2710858A (en) | Making ferrilactin | |
US3936351A (en) | Method for preparing glucoronyl-glucosamino-glycan sulphates exhibiting antilipasaemic activity | |
US2797184A (en) | Process for the recovery of heparin | |
US3518243A (en) | Sulfonated derivatives of a glycopeptide extracted from animal organs,useful as drugs and a process for the preparation thereof | |
US2009868A (en) | Method of preparing leucine | |
US2598341A (en) | Manufacture of protein hydrolysates | |
US2549526A (en) | Process for recovery of vegetable protein | |
US2243871A (en) | Method of making protein products | |
CA1054896A (en) | Process for removing and recovering precipitation agents from precipitate containing proteinous substances | |
FI65073B (en) | FOERFARANDE FOER FRAMSTAELLNING AV HEPARIN | |
GB751287A (en) | Improvements in or relating to process of preparing amino acids | |
GB1480857A (en) | Production of protein isolates | |
US2379912A (en) | Nucleic acid | |
SU531476A3 (en) | The method of obtaining albumin and whey proteins | |
GB872214A (en) | Extraction process for the recovery of heparin | |
GB816281A (en) | Coagulation of lignin in aqueous suspension | |
Robson et al. | A new technique for the estimation and isolation of the hexone bases in protein hydrolysates | |
GB906819A (en) | Parenteral solution for diagnostic test of cancer and a process of preparing same | |
SU406544A1 (en) | METHOD OF OBTAINING GLOBIN | |
GB1239861A (en) | Improvements in or relating to the production of collagen and/or gelatine | |
US2723291A (en) | Treatment of glutamic acid-containing hydrolysates | |
US2758055A (en) | Recovery of enzymes from pancreas gland residues subsequent to insulin removal |